The world’s chocolate industry could be in for a turbulent ride as the two biggest cocoa producers set down demands for manufacturers to pay higher prices for their growers.
The quarrel focuses on the Living Income Differential — a policy that Ivory Coast and Ghana introduced in 2019 to fight poverty among cocoa farmers in the global US$130 billion chocolate market.
Under it, Ivory Coast and Ghana vowed to charge a premium of US$400 per tonne on all cocoa sales, starting with the 2020-2021 harvest.
Photo: AFP
However, trade boards in the countries — the Ivorian Coffee-Cocoa Council (CCC) and the Ghana Cocoa Board (Cocobod) — say the scheme is being undermined as cocoa traders depress the price of another premium that operates in parallel.
“We’ve introduced the Living Income Differential as a means of improving the farmer income,” Cocobod spokesperson Fiifi Boafo said. “You have these companies circumventing these processes to ensure that the Living Income Differential effect is not felt in [their] lives.”
The two countries together account for 60 percent of the world’s cocoa, but their farmers earn less than 6 percent of the industry’s global revenue.
They boycotted a bridge-building meeting in Brussels late last month and set today as a deadline for bringing buyers into line.
They are threatening to punish corporations by barring them from visiting plantations to estimate harvests — a key factor in cocoa price forecasting, and are also threatening to suspend sustainability programs that chocolate giants use to enhance their image with fast-growing ethnic consumers.
“This boycott and also ultimatum is to draw attention to the fact that inasmuch as it is important for us to talk about deforestation, it is important to talk about child labor, it is equally important to talk about the farmer income,” Boafo said.
The Living Income Differential premium is being completed by a price stabilization fund to help buffer the international price of cocoa in the event of big market fluctuations.
Some experts say the chocolate giants have factored the Living Income Differential into their costs but claw back some of this by exerting pressure on another premium based on the quality of cocoa beans.
This premium, known as the origin differential, has plunged below zero in recent years, effectively canceling out part of the Living Income Differential.
COVID-19 is being used as “a pretext not to pay,” CCC president Yves Brahima Kone said. “The thing is, the multinationals have increased their profits — they are able to pay.”
The World Cocoa Foundation, an umbrella group of public entities and corporations aimed at supporting sustainability in the sector, declined to comment on the face-off.
Among corporations, Nestle said it strongly backed efforts for growers to maintain a decent standard of living and had been paying the Living Income Differential since its inception.
Some experts say that time might weigh against Ivory Coast and Ghana if the row escalates.
Virtually all of Ivory Coast’s crop is purchased by roughly half a dozen majors. Of this, about 80 percent heads to Europe, the wealthy market where sustainability factors — environmental and labor criteria — count most for consumers.
“Ivory Coast’s economy is heavily dependent on cocoa income,” one specialist said. “It needs to sell its beans.”
“Stopping sustainability programs is difficult to explain to the general public, and Ivory Coast’s image could [also] suffer,” they said.
Other commodities:
Gold for December delivery fell US$8.60 to US$1,754.40 an ounce, declining 0.85 percent from a week earlier.
Silver for December delivery rose US$0.02 to US$21 an ounce, but lost 3.09 percent on the week, while December copper fell US$0.06 to US$3.63 a pound, down 7.16 percent weekly.
Additional reporting by AP
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
The Investment Commission yesterday approved a Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) application to invest an additional US$3.5 billion in its Arizona subsidiary to manufactured advanced chips. The world’s largest contract chipmaker’s board of directors last month approved the funding project after TSMC started moving manufacturing equipment into the fab in December last year in preparation for the production of 4-nanometer chips next year. TSMC said it has also commenced the second phase of facility construction in Arizona. The second fab is to produce semiconductors using 3-nanometer technology in 2026. Altogether, TSMC plans to spend US$40 billion on the Arizona fabs, doubling its
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
RSS